Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Castillo Lugo

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Boletin De La Asociacion Medica De Puerto Rico|May 1, 1995
Clinical and experimental immunosuppressionJ A Castillo Lugo
Current Opinion in Cardiology|April 7, 1999
An overview of combined heart and kidney transplantationJ A Castillo-Lugo, K R Brinker
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 19, 2007
Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantationS E Wright, Z H A Shaikh, J A Castillo-Lugo, et al.
Transplantation Proceedings|December 23, 2008
High-dose intravenous immunoglobulin and rituximab treatment for antibody-mediated rejection after kidney transplantation: a cost analysisB Tanriover, S E Wright, S V Foster, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Boletin De La Asociacion Medica De Puerto Rico|May 1, 1995
Clinical and experimental immunosuppressionJ A Castillo Lugo
Current Opinion in Cardiology|April 7, 1999
An overview of combined heart and kidney transplantationJ A Castillo-Lugo, K R Brinker
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 19, 2007
Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantationS E Wright, Z H A Shaikh, J A Castillo-Lugo, et al.
Transplantation Proceedings|December 23, 2008
High-dose intravenous immunoglobulin and rituximab treatment for antibody-mediated rejection after kidney transplantation: a cost analysisB Tanriover, S E Wright, S V Foster, et al.
Pageof 1